BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21706236)

  • 1. Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma.
    Hua Y; Jia X; Sun M; Zheng L; Yin L; Zhang L; Cai Z
    Tumour Biol; 2011 Oct; 32(5):1013-21. PubMed ID: 21706236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.
    Zhang Z; Zhang L; Hua Y; Jia X; Li J; Hu S; Peng X; Yang P; Sun M; Ma F; Cai Z
    BMC Cancer; 2010 May; 10():206. PubMed ID: 20470422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
    Posthumadeboer J; Piersma SR; Pham TV; van Egmond PW; Knol JC; Cleton-Jansen AM; van Geer MA; van Beusechem VW; Kaspers GJ; van Royen BJ; Jiménez CR; Helder MN
    Br J Cancer; 2013 Oct; 109(8):2142-54. PubMed ID: 24064975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.
    Pruksakorn D; Teeyakasem P; Klangjorhor J; Chaiyawat P; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Pothacharoen P; Srisomsap C
    Int J Oncol; 2016 Sep; 49(3):903-12. PubMed ID: 27573585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
    Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
    J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
    Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
    Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell lines.
    Guo QC; Shen JN; Jin S; Wang J; Huang G; Zhang LJ; Huang G; Yin JQ; Zou CY; Li MT
    Acta Pharmacol Sin; 2007 Jun; 28(6):850-8. PubMed ID: 17506944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.
    Li C; Tan YX; Zhou H; Ding SJ; Li SJ; Ma DJ; Man XB; Hong Y; Zhang L; Li L; Xia QC; Wu JR; Wang HY; Zeng R
    Proteomics; 2005 Mar; 5(4):1125-39. PubMed ID: 15759316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
    Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cell.
    Liu X; Zeng B; Ma J; Wan C
    Cancer Invest; 2009 Mar; 27(3):345-52. PubMed ID: 19212829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS.
    Lv D; Zou Y; Zeng Z; Yao H; Ding S; Bian Y; Wen L; Xie X
    Metabolomics; 2020 Nov; 16(12):120. PubMed ID: 33210231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies.
    Gemoll T; Epping F; Heinrich L; Fritzsche B; Roblick UJ; Szymczak S; Hartwig S; Depping R; Bruch HP; Thorns C; Lehr S; Paech A; Habermann JK
    Oncotarget; 2015 Jun; 6(18):16517-26. PubMed ID: 26203049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
    Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
    Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
    Xu SG; Yan PJ; Shao ZM
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells.
    Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
    Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.
    Cates JM; Friedman DB; Seeley EH; Dupont WD; Schwartz HS; Holt GE; Caprioli RM; Young PP
    Int J Exp Pathol; 2010 Aug; 91(4):335-49. PubMed ID: 20353421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.